| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/01/2007 | CN101006995A Application of isosteviol in pharmacy |
| 08/01/2007 | CN101006994A Enteric-coated capsules of allimin and its preparation method |
| 08/01/2007 | CN101006993A Soluble slow release external applied contraceptive |
| 08/01/2007 | CN101006992A Propofol freeze-dried emulsion and its preparing method |
| 08/01/2007 | CN101006991A Slow release preparation of berberine |
| 08/01/2007 | CN101006990A Slow release preparation of cilostazol |
| 08/01/2007 | CN101006989A Slow release preparation of alginic sodium diester |
| 08/01/2007 | CN101006988A Slow release preparation of puerarin |
| 08/01/2007 | CN101006987A Slow release preparation of erythromycin |
| 08/01/2007 | CN101006986A Medicinal composition containing mycophonolate mofetil and its preparation method |
| 08/01/2007 | CN101006985A Pharmacological composition |
| 08/01/2007 | CN101006984A An injection preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application |
| 08/01/2007 | CN101006982A Anticancer medicine composition of taxane and its synergist |
| 08/01/2007 | CN101006981A Slow released injection containing taxane and platinum |
| 08/01/2007 | CN101006980A Anticancer composition containing taxane and alkaloids |
| 08/01/2007 | CN101006979A Anticancer composition containing taxane and topoenzyme inhibitor |
| 08/01/2007 | CN101006978A Anticancer medicinal composition containing taxane and alkylating agents |
| 08/01/2007 | CN101006977A Anticancer medicinal composition containing taxane and hormones drug |
| 08/01/2007 | CN101006976A Anticancer medicinal composition of loaded taxane and its synergist |
| 08/01/2007 | CN101006975A An oral medicine preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application |
| 08/01/2007 | CN101006949A A composite intrauterine device using copper salts as copper ion source |
| 08/01/2007 | CN101006945A A vagina administration apparatus for animals, and its preparation method and application |
| 08/01/2007 | CN101006846A Anti-stress nutrition additives for poultry and its preparation method |
| 08/01/2007 | CN101006807A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 08/01/2007 | CN101006806A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 08/01/2007 | CN101006805A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 07/31/2007 | USRE39754 Benzamide derivatives and pharmaceutical compositions containing same |
| 07/31/2007 | US7251525 Treating or preventing arrhythmias in a human subject comprising the administration of an effective amount of a calcium/calmodulin-dependent protein kinase inhibitor. Also provided are pharmaceutical compositions as antiarrhythmia |
| 07/31/2007 | US7251516 Noninvasive glucose sensor |
| 07/31/2007 | US7250551 Inhibiting amyloid precursor protein phosphorylation; using kinase inhibitors; reducing, preventing and/or reversing Alzheimer's symptoms; transgenic mice, cell lines, assays |
| 07/31/2007 | US7250531 Process for the synthesis and crystalline form of agomelatine |
| 07/31/2007 | US7250525 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 07/31/2007 | US7250522 Reacting a 5-thio-D-aldohexopyranose derivative with a hydroxyaromatic compound in the presence of a phosphine and an azo reagent; Mitsunobu reaction conditions; useful as an sodium-dependent glucose transporter (SGLT2) inhibitor; beta-selective glycosylation |
| 07/31/2007 | US7250516 Phenylalanine derivatives |
| 07/31/2007 | US7250511 intermediates in the preparation of derivatives which possess anti-cancer activity; synthesis of 4{N-[(6RS)-2-Methyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl]-N-(prop-2-ynyl)amino}benzoic acid |
| 07/31/2007 | US7250506 Conjugated nucleotides to a detectable fluorescent dye; trancribing primers/probes for replication; qualitative and quantitative analysis of detecting viral nucleic acids |
| 07/31/2007 | US7250447 Acylsulfamide inhibitors of factor VIIa |
| 07/31/2007 | US7250446 For prophylaxis and therapy of medical indications associated with estrogen dependent diseases or syndromes related to osteoporosis, bone loss, bone formation, cardiovascular disorders, neurodegenerative disorders, menopausal disorders, physiological disorders, diabetes disorders, prostatic carcinoma |
| 07/31/2007 | US7250445 Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders |
| 07/31/2007 | US7250444 Pyrrole-based HMG-CoA reductase inhibitors |
| 07/31/2007 | US7250443 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 07/31/2007 | US7250441 Carbazole and cyclopentaindole derivatives to treat infection with Hepatitis C virus |
| 07/31/2007 | US7250440 (Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents |
| 07/31/2007 | US7250439 For therapy of autoimmune disorder or an inflammatory condition |
| 07/31/2007 | US7250438 Anti-bacterial and anti-cancer spiro beta-lactone/gamma-lactams |
| 07/31/2007 | US7250437 Pyrrazoles connnected to a carbocyclic ring by a vinylene, butadienylene or hexatrienylene bridge, e.g. 3(5)-[2-(2-chloro-5-trifluoromethylphenyl)vinyl]-1H-pyrazole; compounds exhibit antifibrotic and antiapoptotic activities |
| 07/31/2007 | US7250435 5-(Thio)Carbonylamino-indeno[1,2-c]pyrazol-4-ones, e.g., 3-(4-methoxyphenyl)-5-(2-phenethylacetylhydrazine carboxamido)indeno[1,2-c]pyrazol-4-one and 3-(4-methoxyphenyl)-5-(2-methoxycarbonyl hydrazinecarboxamido)indeno[1,2-c]pyrazol-4-one |
| 07/31/2007 | US7250434 Diarylimidazoles, substituted with another aromatic ring and one or more carboxylic acids, esters or amides, e.g., 3-[5-Benzo[1,3]dioxol-5-yl-4-(2,5-dichloro-phenyl)-1H-imidazol-2-yl]-2-(3-chloro-phenyl)-acrylic acid; treatment of conditions such as pain, drug dependence, and psychological disorders |
| 07/31/2007 | US7250433 Calcium channel blockers; central nervous system disorders; antiarthritic agents |
| 07/31/2007 | US7250432 Pharmaceutical compositions of diaryl-isoxazole derivatives for the prevention and treatment of cancers |
| 07/31/2007 | US7250431 neuropeptide Y(NPY) receptor antagonists; useful in the treatment of obesity; such as 4-methoxy-N-{4-[5-(2-methyl-benzoyl)-thiazol-2-ylamino]-phenyl}-benzenesulfonamide |
| 07/31/2007 | US7250430 Administering N-benzoyl- derivatives, e.g., N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt, to treat metastatic soft tissue sarcoma, non-small cell lung cancer, melanoma, ovarian cancer, breast cancer, leukemia, lymphoma, renal cancer, prostate cancer, and multiple myeloma |
| 07/31/2007 | US7250429 Aminomethyl-substituted thiazolobenzimidazole compounds |
| 07/31/2007 | US7250428 Cetylpyridinium diclofenac and its preparation by reacting a mineral or organic salt of diclofenac with cetylpyridinium halide or hydroxide in a solvent such as methylene chloride, chloroform, carbon tetrachloride, dichloroethane, trichloroethane, tetrachloroethane, trichloroethylene and trichloropropane |
| 07/31/2007 | US7250427 E.g., 2-[4-(3-Hydroxy-propoxy)-phenyl]-1H-benzoimidazole-5-carboxylic acid amide; inhibitors of checkpoint kinase and useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer. |
| 07/31/2007 | US7250426 acid addition salt of optionally substituted 5-[2-(indan-2-ylamino-1-hydroxyethyl)]-8-hydroxyquinolone; treating respiratory disorders, especially asthma and COPD |
| 07/31/2007 | US7250425 Substituted in the 2 position with phenoxy(or thio)methyl- or naphthyloxy(or thio)methyl- and in the 3 position with alkyl, phenyl-, or naphthyl-, e.g., 2R,3S)-2-(2,3-Dichlorophenoxymethyl)-8-methyl-3-(3-chlorophenyl)-8-aza-bicyclo[3.2.1]octane |
| 07/31/2007 | US7250424 Fab I inhibitors |
| 07/31/2007 | US7250423 Methods for synthesizing heterocycles and therapeutic use of the heterocycles for cancers |
| 07/31/2007 | US7250422 Preventing and inhibiting morphine tolerance caused by repeated administration of morphine, while not affecting the analgesic effects of morphine upon a single administration |
| 07/31/2007 | US7250421 Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase |
| 07/31/2007 | US7250420 Using a pyrrolo(2,3-d)pyrimidine compound |
| 07/31/2007 | US7250419 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 07/31/2007 | US7250418 Corticotropin releasing factor antagonist; antiinflammatory agents; drug abuse; analgesics; antihistamines; skin disorders; neurodegenerative disease; eating disorders;eating disorders; antiepileptic agents; cardiovascular disorders |
| 07/31/2007 | US7250417 Arylmethyl triazolo- and imidazopyrazines as c-Met inhibitors |
| 07/31/2007 | US7250416 Alkyl, substituted or unsubstituted ribose, or 2'-deoxyribose substituted 1,3,5-triazin-2(1H)-ones, which may be additionally substituted with alkyl, aryl, halo, amino, oxy, thio, and/or hydrazine groups; used for treating diseases such as hematological disorders and cancer |
| 07/31/2007 | US7250415 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors |
| 07/31/2007 | US7250414 Antihistamines; bronchodilator agents; respiratory system disorders; 2-{(S)-1-[4-(4-aminophenyl)butyl]pyrrolidin-3-yl}-2,2-diphenylacetamide; chemical synthesis; Bioassay of testing the compound on the biological sample |
| 07/31/2007 | US7250413 C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes |
| 07/31/2007 | US7250412 Diisopropylphenyl esters of N-amino- or N-heterocyclyl-alkanamic acids, e.g., N-(2-Piperidin-1-yl-ethyl)-succinamic acid 2,6-diisopropylphenyl ester; induction and maintenance of anesthesia or sedation |
| 07/31/2007 | US7250411 Benzothiazine and benzothiadiazine compounds |
| 07/31/2007 | US7250410 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
| 07/31/2007 | US7250409 Ningalin B analogs employable for reversing multidrug resistance |
| 07/31/2007 | US7250408 Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility |
| 07/31/2007 | US7250407 For the treatment of disorders associated with dyslipoproteinemia, including cardiovascular disease, atherosclerosis, restenosis, hyperlipidemia, and endotoxemia septic shock |
| 07/31/2007 | US7250405 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 07/31/2007 | US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier |
| 07/31/2007 | US7250402 And use in treating mammals including humans for parasitosis |
| 07/31/2007 | US7250394 Blocking glutamate function at an ionotropic glutamate receptor. e.g., N-methyl-D-aspartate receptor, the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptor and the kainate receptor; brain disorders; spinal chord |
| 07/31/2007 | US7250262 For the diagnosis and treatment of patients with disorders including anemias |
| 07/31/2007 | US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 07/31/2007 | US7250182 Medicament containing Epimedium extract for treatment of prostatic hyperplasia and prostatitis |
| 07/31/2007 | US7250180 Administering to mammal purified extract of the Amazonian variation of Solanaceae Dulcamara root, wherein extract comprise an effective amount of Biological Immune Response Modifier comprising at least one uronate carbohydrate, at least one bio-organic mineral component |
| 07/31/2007 | US7250176 Administering to the patient in need thereof a therapeutically effective amount of a composition in solid form comprising amoxicillin and potassium clavulanate and comprising a first release phase and a second release phase |
| 07/31/2007 | US7250171 Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein |
| 07/31/2007 | US7250165 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2007 | US7250158 7-Hydroxy-3-phenylcoumarin and derivatives in a cosmetically acceptable carrier; reduced irritation |
| 07/31/2007 | US7250157 Dermatological compositions and methods |
| 07/31/2007 | US7250154 Radio-opaque polymeric biomaterials |
| 07/31/2007 | CA2544381C Methods for administration of a farnesyl dibenzodiazepinone |
| 07/31/2007 | CA2412596C Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/31/2007 | CA2398353C Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 07/31/2007 | CA2363531C Vanilloid analogues containing resiniferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof |
| 07/31/2007 | CA2343130C Cosmetic composition |
| 07/31/2007 | CA2333603C New dipeptidyl peptidase iv effectors |
| 07/31/2007 | CA2305612C Halogen substituted tetracyclic tetrahydrofuran derivatives |
| 07/31/2007 | CA2284863C Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
| 07/31/2007 | CA2275306C Novel tetrahydrobenzindolone derivatives |
| 07/31/2007 | CA2270964C Benzonaphthyridines as bronchial therapeutics |
| 07/31/2007 | CA2260584C Androsterone derivatives for inhibiting dna binding of ap-1 and airway smooth muscle proliferation |